Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04155 (
pS2
)
1,234
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Trefoil factor family (TFFs) peptides facilitate epithelial restitution, but also effect cell proliferation and apoptosis of normal and various cancer cell lines. In a recent study by our group, TFF2 expression was demonstrated in the murine retina, where it exhibits pro-proliferative and pro-apoptotic effects. In the present study, we investigated the expression and function of TFF peptides in eight human retinoblastoma cell lines.
TFF1
was the only TFF peptide expressed at detectable levels in immunoblots of retinoblastoma cells.
TFF1
expression levels were highly variable in different retinoblastoma cell lines and negatively correlated with cell growth curves. Recombinant human
TFF1
had a negative effect on cell viability and caused a reduction in cell proliferation. Retinoblastoma cell lines with high
TFF1
expression levels exhibited a selective down-regulation of cyclin-dependent kinase (CDK) 6, whereas CDK4 and
CDK2
seem to be unaffected by
TFF1
expression. In immunocytochemical studies, we observed a nuclear co-localization of
TFF1
and
CDK2
in Cajal bodies (CBs). In high
TFF1
expressing human retinoblastoma cell lines CBs were smaller and higher in number compared to retinoblastoma lines with low
TFF1
expression, indicating differences in cell cycle status between the different retinoblastoma cell lines. Our data further support the notion for a potential tumor suppressor function of
TFF1
. The nuclear localization of
TFF1
in CBs--considered to play a role in cell cycle progression, potentially acting as a platform for CDK-cyclin function-offers a new impetus in the ongoing search for potential
TFF1
interacting proteins.
...
PMID:High trefoil factor 1 (TFF1) expression in human retinoblastoma cells correlates with low growth kinetics, increased cyclin-dependent kinase (CDK) inhibitor levels and a selective down-regulation of CDK6. 2298 8